The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prevalence, screening, treatment, and complications of osteoporosis and osteopenia in Medicare patients with chronic lymphocytic leukemia (CLL).
 
Danielle M. Brander
Consulting or Advisory Role - Abbvie; ArQule; AstraZeneca; Genentech/Abbvie; Pfizer; Pharmacyclics; TG Therapeutics; Verastem
Research Funding - Abbvie (Inst); ArQule (Inst); Ascentage Pharma (Inst); BeiGene (Inst); DTRM (Inst); Genentech (Inst); Juno Therapeutics (Inst); MEI Pharma (Inst); Pharmacyclics/Janssen (Inst); TG Therapeutics (Inst); Tolero Pharmaceuticals (Inst); Verastem (Inst)
 
Kevin C. Oeffinger
No Relationships to Disclose
 
Melissa A. Greiner
No Relationships to Disclose
 
Michaela Ann Dinan
Research Funding - AstraZeneca (Inst)